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EDITORIAL COMMENT
Re: Drossaerts J, Vrijens D, Leue C, Schilders I,
Van Kerrebroeck P, Van Koeveringe G. Screening for
Depression and Anxiety in PatientsWith Storage or Voiding
Dysfunction: A Retrospective Cohort Study Predicting
Outcome of Sacral Neuromodulation Treatment. Neurourol
Urodyn. 2015
This is a very interesting study focusing on the assessment of
relationships between affective disorders and failure of Sacral
Neuromodulation (SNM) in treating Overactive Bladder (OAB)
or Non-obstructive Urinary Retention (NOR). Although retro-
spective, this study analyses the topic by means of validated
questionnaires, robust criteria (e.g., excluding patients under-
going active treatment for psychiatric disorders at the time of
study) and adequate statistics.
The authors found no significant relation between
depression or anxiety and failure of SNM in their group
of patients.
Despite other similar studies reported in the literature,
concluding that psychological screening for personality traits or
psychiatric status is not useful in predicting the success of SNM,
wemust also consider the heterogeneity of patients complaining
of OAB or NOR: for example, if we focus on patients with
Fibromyalgia (in which OAB is documented in percentages
varying from20% to 70%,1,2) psychological disorders undoubtedly
appear (see new diagnostic criteria for Fibromyalgia recom-
mended in 2010.3) As these patients may have several benefits
from SNM,4 in these particular cases preliminary assessment of
psychological status could be useful for early identification of
personality profiles of patients in whom SNMmay fail.
In our experience, we find it useful to administer a
psychometric test (e.g., MMPI) prior to deciding to subject a
patient with Fibromyalgia to SNM for OAB.
Further studies applying psychological instruments to assess
specific personality disorders associated with OAB or NOR are
needed, to predict SNM outcomes in particular subgroups of
patients with urinary and psychiatric disorders, such as
Fibromyalgia.
Fabrizio Dal Moro*
Department of Surgical, Oncological and Gastroenterological
Sciences University of Padova, Italy
REFERENCES
1. Chung JH, Kim SA, Choi BY, et al. The association between overactive bladder
and fibromyalgia syndrome: a community survey. Neurourol Urodynam
2013;32:66–9.
2. Smith HS, Harris R, Clauw Fibromyalgia D. An afferent processing disorder
leading to a complex pain generalized syndrome Pain Physician 2011;14:
E217–E245.
3. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of
Rheumatology preliminary diagnostic criteria for fibromyalgia andmeasure-
ment of symptom severity. Arthritis Care Res 2010;62:600–10.
4. Dal Moro F. Overactive bladder and fibromyalgia: The true story Neurourol
Urodynam 2014;33:367.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
NAU-15-0259(22870)
Potential conflicts of interest: Christopher Chapple led the peer-review process as
the Associate Editor responsible for the paper.
!Correspondence to: Fabrizio Dal Moro, Department of Surgical, Oncological and
Gastroenterological Sciences University of Padova, Italy.
E-mail: fabrizio.dalmoro@unipd.it
Received 10 August 2015; Accepted 10 August 2015
Published online in Wiley Online Library
(wileyonlinelibrary.com).
DOI 10.1002/nau.22870
# 2015 Wiley Periodicals, Inc.
